Dr. Hu Xiang, North Branch Biology: Small Cells Are Related to Big Health

Read: Hear the story of this cell pioneer's strugglein the 1960s, Hu Xiang was born in Guizhou Province, a strong medical style of the family, ear-to-ear, Hu Xiang small age set up the ambition of studying medicineIn 1991, Hu Xiangyuan crossed the ocean and began more than ten years of overseas study workDuring this period, Hu Xiang was exposed to the international frontier in the field of life science - cell technologyIn 2005, Hu Xiang decided to return home to start a business, and chose to set up Beike Bio in Shenzhen, becoming the first company in China to focus on stem cell basic research and clinical transformationXiao xiao had the honor of interviewing DrHu Xiang and listening to the story of the pioneer of the cell fieldShenzhen is the place where the dream began
9 a.m., the reporter walked into DrHu Xiang's office, suddenly there was a sense of sudden open-mindednessThe office is full of flowers, trees, water, natural wooden seating, books, fitness equipment..It's all about the extremely self-disciplined lifestyle of the office ownerLooking out of the window from DrHu Xiang's office, Baidu International Headquarters, Tencent and other companies towering high." The night before yesterday busy into the early morning, at this time has received three waves of visiting guests, DrHu Xiang is still in good spirits, not the slightest tired"The pace of our work has become a bit like the Internet companies, and of course that's a good thing, because productivity and results can be dramatically improved, " he says with a laugh1998, American developmental biologist James Thomson first isolated human embryonic stem cells, building the first human embryonic stem cell line, and published an article in the journal Science This achievement caught Dr Hu Xiang's attention "It's a very interesting study!" Cells are the basic components of the human body, once in control of the cells, we can use their own repair mechanism for the human body repair and disease treatment "At the time, Hu Xiang was doing postdoctoral studies in Canada Intuition tells him that stem cells will be a revolutionary study July 2005, Dr Hu Xiang founded Beike Bio in the "World Science and Technology Innovation Highlands" - Nanshan Science and Technology Park, located on the shore of the beautiful Shenzhen Bay, dedicated to stem cell foundation and clinical transformation research, to promote stem cell therapy from the laboratory to clinical Beike Bio is also the earliest state-level high-tech enterprise specializing in biological cell research and development, clinical transformation and technology services the seeds that store life
the human body is made up of 50-60 trillion cells, normal people produce 3000-6000 cancerous cells a day, we do not get cancer is not a lucky, but because immune cells at any time to monitor and remove disease-damaged, aging, cancerous cells As the number and quality of immune cells decline, aging and disease follow Dr Hu Xiang thought, if we protect the health of the safety guard - immune cells stored in advance, can better prevent, treat cancer chronic diseases and fight aging? in the past, Beiko bio-stored cells were mainly targeted at newborns because the umbilical cord was a very good source of stem cell transplantation Now, dr Hu says, with the development of science, it is possible that each of us will have to store immune cells As the World Health Organization defines disease and aging, the most fundamental way to cure disease and fight aging is to repair cell damage, improve cell metabolism, and activate cell function With the passage of time and technology, the use of gene therapy, cell therapy, tissue engineering through the human body's own ability to repair diseases and extend life, will become a medical routine He further explained, "We save healthy seed immune cells in advance, so that we can do it with young healthy immune cells in 20 to 30 years' time when cell therapy, gene therapy, or tissue engineering is needed." In Dr Hu Xiang's view, the biggest challenge facing storing immune cells today is advocacy and education Over the past few years, we believe that the most important work should be to treat the disease, relieve the suffering of the patient, and use advanced technology to cure the incurable disease However, with scientific advances, we have found that autologous immune cells are the best medicine in the world In recent years, Beike has laid out the national network of "integrated cell bank and regional cell preparation center", hoping to provide the nation's people with internationally synchronized cell storage services to develop industry standards
as a pioneer in the field of cell science in China, Beike Bio recognized that strict quality management system is the fundamental support for the clinical transformation of cell therapy technology Beiko biocellular preparation process is extremely demanding, with the industry's highest standard aABB (global advanced blood transfusion and cell therapy technology alliance) quality assurance, "produced" each cell has 580 copies of standard documents, 740 plus quality records, to ensure that each cell has traceability, traceability, the whole process to ensure cell quality and safety Dr Hu Xiang said seriously, "If our cell preparation process is not perfect, it will affect the quality and eligibility of cells, if the stored cells fail edigate will have serious consequences, just like the non-conforming vaccine to the market." Because we can't buy back the time, the responsibility in this is so great that we can't get a little bit of a gap pool "
cell preparation technology for Beiko Bio is continuously certified by the Global Alliance of Advanced Blood Transfusion and Cell Therapy Technologies (AABB) AABB is the world's highest standard of certification for cell therapy services and is reviewed every two years Dr Hu Xiang said that Beike Bio, as a leader in the industry, is actively promoting the establishment of a third-party quality control system to promote the healthy development of the industry in July this year, with China's first independent third-party cell quality verification platform - Shenzhen Kono - officially qualified to practice, cell quality has an "independent referee." This is expected to promote the quality of Life and Health industry in Shenzhen and the whole country And each cell of The Shenzhen comprehensive cell bank, by the Shenzhen Kono cell technology quality verification, which is equal to the strict and strict north cell quality, and added a third-party verification of the "safety pass." business development is running a marathon
for Dr Hu Xiang, the storage of immune cells is only the beginning, he has a greater "ambition" - to obtain interrelated life data "Tens of thousands of data, including genomes, transcriptions, proteomes, metablegroups, and even microbiomes, will be used to provide a reference value for disease and health judgments through algorithmic analysis by artificial intelligence." "Obviously, Hu Xiang has his vision - if we have a large number of specimens, read out the health-related group data inside, and then use it to train artificial intelligence, our clinical diagnosis in the future can be more accurate, efficient, and can be done at an early stage, even replacing traditional non-friendly testing methods." And beetho bio-use big data and artificial intelligence, may have the opportunity to be at the forefront of health management, disease diagnosis and treatment Dr Hu Xiang said that Beiko biowashesively catching up with the rapid development of the cell age In the past, the biggest constraint sway of enterprise development is the policy and regulation and mechanism system, now from the central government to local governments are emphasizing innovation, this change lets technology enterprises see great opportunities, we need to adjust the business model in a timely manner, efficient integration of resources to develop In recent years, Beike Bio has also transformed from a research and development-oriented enterprise to a platform-driven enterprise, the company's goal is not only a stem cell research and development company, but also hope to build a platform for the entire industry Under the new track, Beiko needs to adjust the pace of development to see whether it is to run a hundred meters or a marathon